Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens

Author(s):
Burg, S.H. van der; Kwappenberg, K.M.C.; O'Neill, T.; Brandt, R.M.P.; Melief, C.J.M.; Hickling, J.K.; Offringa, R.
Published
2001
Publication type
Article / Letter to editor
Date issued
2001
Language
English
Publisher
Elsevier
Is part of
Vaccine (2001), Vol. 19, p. 3652-3660
hdl
1887/8760